Kyongbo Pharmaceutical Co., Ltd

KRX:214390.KS

5010 (KRW) • At close July 1, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) KRW.

20242023202220212020201920182017201620152014
Omzet 238,556.126216,357.482196,264.902170,659.645215,285.095191,706.189201,343.596191,661.374186,726.17178,032.632169,781.246
Kosten van de omzet 156,135.778153,282.206151,847.03135,299.352162,820.355150,990.036152,082.417137,038.683142,622.767129,475.387119,975.881
Brutowinst 82,420.34863,075.27644,417.87235,360.29352,464.7440,716.15349,261.17854,622.69144,103.40348,557.24549,805.365
Brutowinstmarge 0.3450.2920.2260.2070.2440.2120.2450.2850.2360.2730.293
Onderzoek- en ontwikkelingskosten 5,312.4333,653.6093,076.8365,053.2636,238.2381,418.246769.777765.4031,484.4581,866.7381,251.438
Algemene en administratieve kosten 2,361.2572,381.3951,913.6112,288.2772,930.5243,979.3323,289.8914,372.124,434.4333,554.9511,873.968
Verkoop- en marketingkosten 44,680.59233,402.08522,122.86117,153.55411,403.9588,874.7638,006.7817,895.9826,425.0995,171.146,115.969
Verkoop-, algemene en administratieve kosten 47,041.84935,783.4824,036.47219,441.83114,334.48212,854.09511,296.67212,268.10210,859.5328,726.0917,989.937
Overige kosten 19,612.33818,093.41515,911.91217,490.04323,230.58820,249.739266.6272,191.657778.574648.9763,312.286
Bedrijfskosten 71,966.6257,530.50443,025.2241,985.13743,803.30834,522.0831,994.60430,036.04228,509.17622,924.9122,136.802
Bedrijfsresultaat 10,453.7285,544.7721,392.652-4,595.425,677.2136,194.07317,266.57524,586.64915,594.22725,632.33527,668.563
Bedrijfsresultaat ratio 0.0440.0260.007-0.0270.0260.0320.0860.1280.0840.1440.163
Totaal overige inkomsten en kosten netto -5,550.688-3,372.848-2,007.485-3,308.1032,399.183-1,293.008-1,200.948-325.611-1,496.967-100.0261,343.271
Inkomen voor belasting 4,903.042,171.924-614.836-9,932.94714,030.7936,982.15417,643.54824,261.03915,643.08625,532.30930,034.305
Inkomen voor belasting ratio 0.0210.01-0.003-0.0580.0650.0360.0880.1270.0840.1430.177
Belastingkosten 263.715-802.476-1,225.426-2,437.7684,626.3461,696.9144,527.4986,297.7292,937.156-577.31421,398.351
Nettowinst 4,639.3262,974.4610.59-7,495.1799,404.4465,285.23913,116.04917,963.3112,705.9326,109.6238,635.954
Nettowinstmarge 0.0190.0140.003-0.0440.0440.0280.0650.0940.0680.1470.051
WPA (Winst Per Aandeel) 194.06124.4225.54-313.52393.38221.085497515311,147401
Verwaterde WPA 194.06124.4225.54-313.52393.38221.085497515311,147401
EBITDA 21,600.6917,243.59213,328.3884,212.09521,249.37618,783.22828,824.44536,054.10526,033.97433,910.92334,871.188
EBITDA ratio 0.0910.080.0680.0250.0990.0980.1430.1880.1390.190.205